Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Does Makary’s Reorg Choice Mark FDA Turning Point?

May 05 2025

• By Michael McCaughan

Figurine of man standing at crossroads — (Hyejin Kang/Shutterstock)

Related Content

US FDA Restructuring May Be Next After Drugs Center Loses More Than 1,000 People

Apr 03 2025

US FDA Survives First Day Of Return To In-Office Work, But True Test Upcoming

Mar 17 2025

HHS’ Kennedy Warns US FDA Staff Against ‘Agency Capture’ By Industry, Special Interests

Apr 11 2025

All US FDA Product Centers May Merge Under Planned Agency Reorganization

Apr 04 2025

US FDA Commissioner Rejected Some Proposed Reorg Plans

Apr 29 2025

US FDA Retirements Continue Unabated With Drug Inspectorate Leaders, Former Chief Counsel

Apr 24 2025

More from Policy & Regulation

More from US FDA

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window